Concourse Financial Group Securities, Inc. Pax Medica, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023
BUY
$0.27 - $0.88 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$0.27 - $0.88 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$0.76 - $2.08 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$1.42 - $3.62 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$1.4 - $53.55 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$2.25 - $43.69 $0 - $0
0 New
0 $0

About PaxMedica, Inc.

PXMD Quotes by TradingView
  • Ticker PXMD
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,779,500
  • Market Cap $1.06M
  • Description
  • PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, my...
More about PXMD
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email